Hi [[ session.user.profile.firstName ]]

Beckman Coulter

  • Date
  • Rating
  • Views
  • The Laboratory’s Role in the National Healthcare Safety Network
    The Laboratory’s Role in the National Healthcare Safety Network Robert L. Sautter, Ph.D., HCLD (ABB), CC Recorded: Mar 9 2018 47 mins
    In this webinar, Dr. Sautter will discuss the important collaboration efforts between the government and healthcare facilities to stop prevalent and dangerous hospital-acquired infections.
  • The Role and Limitations of Sigma Analysis in Lab QC
    The Role and Limitations of Sigma Analysis in Lab QC Jack Montgomery, MLS(ASCP)cm Recorded: Nov 15 2017 54 mins
    Hear Jack Montgomery share his experiences and methodologies in applying sigma analysis to lab quality control at Asante Health, a Truven Health Analytics Top 100 hospital the past four years.

    In this webinar, Jack will discuss the dynamic nature of sigma metrics for clinical chemistry analytes. He will show how they can be improved over time with enhanced monitoring and optimized maintenance schedules. This sensitivity of sigma metrics highlights the notion that sigma methodology is just one of the many tools that should be used for a holistic approach to lab quality.

    By attending this webinar, you will:
    - Understand the practical use of Six Sigma as a lab quality tool
    - Learn about the dynamic nature of sigma metrics and how they can be improved in the lab
    - Gain insights into the additional tools for implementing a multi-faceted total quality program

    P.A.C.E. credit is available for your participation.*

    Presenter:
    Jack Montgomery, MLS(ASCP)cm, is the chemistry technical specialist for Rogue Regional Medical Center—the flagship entity for Asante Health—a growing three-hospital system located in southern Oregon containing a laboratory accredited by the College of American Pathologists. Jack has over 40 years of experience in the clinical laboratory with a special interest in quality control, sigma metrics and method validation.

    *Beckman Coulter, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program. These credits are recognized by the State of California. Most programs also provide State of Florida credits (with valid license number). At this time we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.
  • Innovations in Multivariate Hematology Analysis
    Innovations in Multivariate Hematology Analysis Gert-Jan van de Geijn, Ph.D. Recorded: Oct 5 2017 51 mins
    In this on-demand webinar, Dr. Gert-Jan van de Geijn, renowned hematology expert, researcher and industry leader, discusses new chronic obstructive pulmonary disease (COPD) test parameters that better discriminate between bacterial and nonbacterial acute exacerbation. Dr. van de Geijn shares how neutro/lympho ratios and basophils (measured by flow) combined with current C-reactive protein (CRP) tests enable more accurate bacterial detection in COPD patients.

    After viewing this webinar, you will be able to:

    - Assess options based on the limitations of current differentiation tests (e.g., sputum culture and CRP)
    - Apply multivariate analysis results from hematology and flow cytometry technologies to increase specificity
    - Combine tests to improve prediction of bacterial exacerbation in COPD patients to help reduce antibiotics resistance

    For more insight, watch a recorded Q&A session that followed the live webinar.

    P.A.C.E. credit is available for your participation.*

    Gert-Jan van de Geijn, Ph.D., has nearly 20 years of experience in hematology and laboratory medicine. He is a specialist in multiple technologies related to cellular analysis, including both flow cytometry and molecular biological techniques. He has published and contributed to more than 30 research articles. Currently, Dr. van de Geijn is a research coordinator for the Department of Clinical Chemistry at Franciscus Gasthius Hospital, Rotterdam, the Netherlands.

    *Beckman Coulter, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. These credits are recognized by the State of California. At this time, we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.
  • Tools For Assessing Iron Status
    Tools For Assessing Iron Status Eloísa Urrechaga, M.D., Ph.D. Recorded: May 31 2017 42 mins
    In this on-demand webinar, Eloísa Urrechaga, M.D., Ph.D., discusses the importance of iron status assessment in accurately diagnosing and treating anemia. The complexities of anemia require solutions that help meet the daily challenges of distinguishing iron deficiency anemia (IDA) and isolating anemia of chronic diseases (ACD) from the combined state of IDA/ACD.

    After viewing this webinar, you will be able to:

    • Discuss current advancements in anemia diagnosis
    • More clearly understand the role of accurate iron status assessment
    • Cite the latest research experience with Beckman Coulter analyzers in assessing iron status

    P.A.C.E. credit is available for your participation.*

    Presenter:
    Eloísa Urrechaga, M.D., Ph.D., has more than 30 years of experience in hematology and laboratory medicine. She is a specialist in clinical analysis technology, robotics in hematology, iron and anemia, erythropoiesis and glycohemoglobin. Currently, Dr. Urrechaga is responsible for the hematology laboratory at the Hospital Galdakao-Usansolo in Spain.

    Dr. Urrechaga contributes her expertise to the Spanish Science and Innovation Ministry by assessing new technologies. She also provides counsel to the Health Research Council for the validation of research projects in the Czech Republic and Argentina. In addition, she is a member of several international organizations, such as the World Health Organization Guideline Development Group and European Network for Rare and Congenital Anaemias. Dr. Urrechaga also serves as an editorial board member and scientific reviewer for a number of journals.

    *Beckman Coulter Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. These credits are recognized by the State of California. At this time, we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.
  • Precise Cell Volume Analysis
    Precise Cell Volume Analysis Elena Lazarova, M.D. Recorded: Mar 15 2017 42 mins
    Dr. Elena Lazarova discusses the value of precise cell volume measurement in differentiating for blood disorders and its importance in effective patient care. Gaining information about cell volume at different stages in the maturation process provides important insight into a patient’s underlying pathology and may have added value in the diagnosis of blood disorders. Beckman Coulter offers precise cell volume measurement* through the advanced technology and sophisticated algorithms of its uniquely designed DxH 800 hematology systems.

    After the webinar, you will be able to:

    • Cite the challenges laboratories face in differentiating for rare types of anemia
    • Outline the benefits of flow cytometric reticulocyte analysis, available on the DxH 800 platform
    • Understand the value of precise cellular volume measurement* to aid in the differential diagnosis of anemia

    **P.A.C.E. credit is available for your participation.

    Presenter:
    Dr. Elena Lazarova earned her M.D. degree from the Medical University of Varna, Bulgaria, in 2002. With over 10 years of experience in clinical and laboratory hematology, immunohematology and transfusion medicine, Dr. Lazarova is a highly sought-after teacher and lecturer. She has authored/co-authored seven medical journal articles and has served as primary author on 17 poster and oral presentations at congresses throughout the world. Dr. Lazarova continues her work in laboratory medicine, focusing on hemoglobinopathies and red blood cell pathologies (hereditary spherocytosis and autoimmune hemolytic anemia) in laboratories at Hôpital Erasme in Brussels.

    *For research use only and not cleared by the FDA for clinical diagnosis

    **Beckman Coulter Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. @ Program. These credits are recognized by the State of California. Most programs also provide State of Florida credits.
  • How do you Decide Whom to Biopsy for Prostate Cancer?
    How do you Decide Whom to Biopsy for Prostate Cancer? Dr. E. David Crawford Recorded: Feb 17 2017 61 mins
    In our webinar, Identifying Men with Prostate Cancer—The Role of phi and Other Biomarkers, Dr. E. David Crawford will discuss key issues that challenge a physician's ability to make informed decisions regarding whom to biopsy for prostate cancer. After the webinar, you will be able to:

    • Understand the historical perspective and controversy regarding prostate-specific antigen (PSA) screening

    • Improve your interpretation of a PSA result

    • Use biomarkers, such as Prostate Health Index (phi), to reduce negative biopsies and have more confidence in the decision to biopsy

    • Understand how the phi score, combined with family and patient history, can determine patient management decisions

    Dr. Crawford is an internationally renowned urologist and distinguished endowed professor of surgery, urology and radiation oncology. He also serves as the head of the section of urologic oncology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado. Dr. Crawford received his medical degree from the University of Cincinnati. His postgraduate training included an internship and residency in urology at the Good Samaritan Hospital in Cincinnati. He subsequently completed a genitourinary cancer fellowship at the University of California Medical Center in Los Angeles.
  • Comparing Automated Microscopy Data to Manual Review
    Comparing Automated Microscopy Data to Manual Review Dr. Michael Samoszuk Recorded: Jan 11 2017 26 mins
    Are you having difficulty categorizing urine sediment particles due to operator subjectivity?

    Automating urine sediment microscopy can help standardize particle characterization. In the final installment of our miniseries, Dr. Michael Samoszuk presents automated and manual microscopy study data from Dr. Sorin Gîju, clinical chemist at the Clinical Emergency Hospital in Timisoara, Romania.

    Dr. Samoszuk compares results from the iRICELL3000 automated microscopy system and manual microscopy for the same patient samples. The iRICELL3000’s proprietary Digital Flow Morphology technology captures 500 images per sample and offers 12-particle classification, resulting in fewer opportunities to miss urine particles.

    Watch this webinar to enhance your understanding of your urinalysis results.

    Presenter:
    Dr. Michael Samoszuk, M.D., vice president and chief medical officer of Beckman Coulter Diagnostics is a graduate of Harvard Medical School, Boston, and completed his postgraduate training at Brigham and Women's Hospital, Boston; University of California, San Francisco; and University of Southern California, Los Angeles. As an experienced chief medical officer, director of hemapathology and associate professor of pathology and radiology, Dr. Samoszuk contributes his expertise to Beckman Coulter’s diagnostics division. His guidance supports product and process developments as well as performance enhancements with patients and clinicians in mind.
  • Adjusting Data Parameters to Improve Results and Workflow
    Adjusting Data Parameters to Improve Results and Workflow Dr. Michael Samoszuk Recorded: Dec 7 2016 18 mins
    How do you know when your result parameters are set to their most efficient ranges?

    In part two of our three-part webinar series, Dr. Michael Samoszuk highlights the correlative relationships between urine chemistry data and urine microscopy data on Beckman Coulter’s Iris iRICELL3000. Learn how these correlations can help you optimize the customizable auto-release function and reduce your laboratory’s manual workload.

    Presenter:
    Michael Samoszuk, M.D., vice president and chief medical officer of Beckman Coulter Diagnostics, is a graduate of Harvard Medical School, Boston, and completed his postgraduate training at Brigham and Women's Hospital, Boston; University of California, San Francisco; and University of Southern California, Los Angeles. As an experienced chief medical officer, director of hemapathology and associate professor of pathology and radiology, Dr. Samoszuk contributes his expertise to Beckman Coulter’s diagnostics division. His guidance supports product and process developments as well as performance enhancements with patients and clinicians in mind.
  • Red Blood Cell Data Correlation between Urinalysis Methods
    Red Blood Cell Data Correlation between Urinalysis Methods Dr. Michael Samoszuk Recorded: Nov 16 2016 21 mins
    What does it mean when you have positive urine chemistry red blood cell (RBC) results but see no RBCs under the microscope?

    In part one of our webinar series, Dr. Michael Samoszuk illustrates which properties of RBCs interact chemically with iRICELL3000 urine test strips to cause positive urine chemistry results, even in the absence of whole RBCs under the microscope.

    Watch this webinar to learn more about the cause of contrasting results between urine chemistry and urine microscopy and understand why your results may still be in perfect correlation.

    Presenter:
    Michael Samoszuk, M.D., vice president and chief medical officer of Beckman Coulter Diagnostics, is a graduate of Harvard Medical School, Boston, and completed his postgraduate training at Brigham and Women's Hospital, Boston; University of California, San Francisco; and University of Southern California, Los Angeles. As an experienced chief medical officer, director of hemapathology and associate professor of pathology and radiology, Dr. Samoszuk contributes his expertise to Beckman Coulter’s Diagnostics His guidance supports product and process developments as well as performance enhancements with patients and clinicians in mind.
  • Emerging Topics in Antibiotic Resistance
    Emerging Topics in Antibiotic Resistance Barbara Zimmer, Ph.D. Recorded: Oct 12 2016 58 mins
    Superbugs are a significant health threat in the U.S. and around the world, making proper detection more important than ever for both patient care and infection control. In this webinar, Dr. Barbara L. Zimmer discusses the mechanisms of resistance that are most concerning to the Centers for Disease Control.

    Get an in-depth review of the classes of beta-lactamase resistance found in Enterobacteriaceae and the challenges associated with detection in the laboratory. Dr. Zimmer will also cover new resistance mechanisms such as mecC-mediated MRSA, colistin-resistant Enterobacteriaceae and antibiotic-resistant Candida species.

    P.A.C.E. credit is available for your participation.*

    Presenter: Barbara L. Zimmer, Ph.D., is a principal scientist of scientific affairs for Beckman Coulter Microbiology. She is also a lecturer in mycology and infectious diseases in the department of dermatology at the University of California, Davis, School of Medicine. Dr. Zimmer is a voting member of the CLSI Subcommittee on Antimicrobial Susceptibility Testing. She was previously on the Board of Scientific Counselors Antimicrobial Resistance Working Group for the CDC and is the past industry advisor to the Microbiology Devices Panel of the Food and Drug Administration. She is the author of over 30 papers and 130 posters and has presented more than 100 scientific workshops.

    *Beckman Coulter Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. These credits are recognized by the State of California. At this time, we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.

Embed in website or blog